Akebia Therapeutics (AKBA) Stock Price Target 2026

The average analyst price target for Akebia Therapeutics is $4.29, 961.6% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $1 to $7.50. The latest change came on Nov 6, 2026, when HC Wainwright & Co. lowered its price target on Akebia Therapeutics from $6 to $4 and kept a Buy rating.